# Best AI Medical Diagnostic Platforms - Page 2

## How Many AI Medical Diagnostic Platforms Products Does G2 Track?

**Total Products under this Category:** 28

### Category Stats (Aug 2026)

- **Average Rating:** 4.53/5 The average rating of products in this category, based on all submitted ratings

_Last updated: August 04, 2026_

## How Does G2 Rank AI Medical Diagnostic Platforms Products?

**Why You Can Trust G2's Software Rankings:**

- 30 Analysts and Data Experts
- 0+ Authentic Reviews
- 28+ Products
- Unbiased Rankings

G2's software rankings are built on verified user reviews, rigorous moderation, and a consistent research methodology maintained by a team of analysts and data experts. Each product is measured using the same transparent criteria, with no paid placement or vendor influence. While reviews reflect real user experiences, which can be subjective, they offer valuable insight into how software performs in the hands of professionals. Together, these inputs power the G2 Score, a standardized way to compare tools within every category.

**Sponsored**

### Aptean Apparel ERP Exenta Edition

Aptean Apparel ERP Exenta Edition is a solution crafted specifically for the fashion and apparel industry and is offered in both the cloud or on premise. This end-to-end system streamlines business processes, from supply chain and production to order management and financial controls, all in a single, integrated platform. The software is ideal for medium to large fashion and apparel brands, wholesalers, distributors, and manufacturers. It's also scalable for growing small businesses. With features like real-time inventory tracking, demand forecasting, and paperless warehouse management, Aptean Apparel ERP Exenta Edition helps brands adapt quickly to industry demands, improve productivity, and increase profitability. It enhances operational efficiency, supports global compliance standards, and scales easily as businesses grow. This ERP solution is ideal for companies that need a robust system to keep up with consumer trends while optimizing every step of the supply chain. A sample of features at a glance: • End-to-End Apparel ERP: Manages production, supply chain, inventory, and more all in one place. • Supply Chain Management: Accurate demand forecasting and cost reduction with pre-built, as well as user created reporting, through a built-in report builder. • Warehouse Management: Streamlined inventory accuracy and reduced chargebacks with paperless workflow. • Electronic Data Interchange (EDI): Fully embedded EDI for seamless communication with customers. • Financial Management: Integrated financial controls and reporting to meet compliance standards. • Seamless Integrations: Connects effortlessly with B2C/B2B ecommerce, 3PLs, shipping, payment, and return systems, enabling seamless workflows and efficiency gains. • Product Lifecycle Management Integration: Optimizes product development cycles, from concept to launch. • Shop Floor Control Integration: Real-time visibility and production tracking to ensure on-time deliveries. Interested in learning more? Contact us today for a free no-obligation consultation or demo tailored to your needs.

[Visit website](https://www.g2.com/external_clickthroughs/record?secure%5Bad_program%5D=ppc&secure%5Bad_slot%5D=category_product_list_llm&secure%5Bcategory_id%5D=1012634&secure%5Bchosen_at%5D=2026-08-05T17%3A47%3A48Z&secure%5Bdisplayable_resource_id%5D=233&secure%5Bdisplayable_resource_type%5D=Category&secure%5Bmedium%5D=sponsored&secure%5Bplacement_reason%5D=retargeted_product&secure%5Bplacement_resource_ids%5D%5B%5D=1402653&secure%5Bprioritized%5D=false&secure%5Bproduct_id%5D=1402653&secure%5Bresource_id%5D=1012634&secure%5Bresource_type%5D=Category&secure%5Bsource_type%5D=category_page&secure%5Bsource_url%5D=https%3A%2F%2Fwww.g2.com%2Fcategories%2Fai-medical-diagnostic-platforms%3Fpage%3D2&secure%5Btoken%5D=086c5e4250bcf5aa6e6434c17b11a5cf859ee59912f64ae7069466f96c583734&secure%5Burl%5D=https%3A%2F%2Fwww.aptean.com%2Fen-US%2Fsolutions%2Ferp%2Fproducts%2Fexenta-erp%3Futm_source%3Dg2%26utm_medium%3Dcpc%26utm_campaign%3Dg2clicks-exenta-erp&secure%5Burl_type%5D=custom_url)

### [MSK X-Ray Reporting](https://www.g2.com/products/msk-x-ray-reporting/reviews)

qMSK is an AI-powered assistant designed to enhance the interpretation and reporting of musculoskeletal (MSK) X-rays, particularly in trauma cases. It analyzes radiographs across 15 anatomical regions—including the clavicle, ribs, shoulder, humerus, elbow, forearm, wrist, hand/fingers, hip, pelvis, femur, knee, tibia-fibula, ankle, and foot/toe—to detect signs of fractures. The system processes scans in under 20 seconds, providing outputs such as bounding boxes highlighting suspected fracture sites and summaries of AI findings.

#### Who Is the Company Behind MSK X-Ray Reporting?

- **Seller:** [Qure.ai](https://www.g2.com/sellers/qure-ai)
- **Year Founded:** 2016
- **HQ Location:** New York , United States
- **LinkedIn® Page:** [www.linkedin.com](https://www.g2.com/external_clickthroughs/record?secure%5Bsource_type%5D=product_profile&secure%5Btoken%5D=907121f84b527eab0597c7e59bae5c35bbde20dd20fe3786b8a15894aa43e0dd&secure%5Burl%5D=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fqure.ai%2F&secure%5Burl_type%5D=linkedin_company_website)  
312 employees on LinkedIn®

### [myExam Companion](https://www.g2.com/products/myexam-companion/reviews)

myExam Companion is an intelligent imaging solution developed by Siemens Healthineers that leverages digitalization and artificial intelligence to transform medical imaging procedures. By converting data into integrated expertise, it assists users in efficiently achieving reproducible results, regardless of their experience level, patient variability, or procedural complexity. This system guides operators through diagnostic procedures, facilitating natural and easy interaction with both patients and technology, thereby ensuring consistent and comprehensive imaging outcomes. Key Features and Functionality: - Built-in Knowledge: myExam Companion transforms data into embedded expertise, simplifying scan procedures and reducing complexity for users across various experience levels. - Intuitive Interfaces: Utilizing clinical language and straightforward visuals, the system simplifies operation, even for unfamiliar imaging modalities, enabling users to focus more effectively on patient care and image acquisition. - Intelligent Guidance: The system offers proactive assistance, helping users navigate imaging procedures with ease. It optimizes acquisition and reconstruction parameters tailored to individual patients and procedures, enhancing efficiency and consistency. Primary Value and User Solutions: myExam Companion addresses the challenges of complex imaging operations by providing intelligent automation and guidance, which leads to: - Enhanced Consistency: Ensures uniform imaging results across different users, patients, and procedures. - Increased Efficiency: Streamlines workflows, reducing the time and effort required for imaging procedures. - Improved Diagnostic Confidence: Delivers high-quality, reproducible images that support accurate diagnoses. By integrating myExam Companion into their imaging systems, healthcare providers can unlock the full potential of their medical imaging devices, leading to better patient outcomes and optimized operational performance.

#### Who Is the Company Behind myExam Companion?

- **Seller:** [Siemens Healthineers](https://www.g2.com/sellers/siemens-healthineers-b376b7c5-19c5-4728-a1a6-97d6f04d8b2a)
- **Year Founded:** 2008
- **HQ Location:** Forchheim, DE
- **Twitter:** @SiemensHealth  
79,729 Twitter followers
- **LinkedIn® Page:** [www.linkedin.com](https://www.g2.com/external_clickthroughs/record?secure%5Bsource_type%5D=product_profile&secure%5Btoken%5D=2c030909f534ab57b8e9406db3ea84468453493acd0379f97c85ba223b3b099d&secure%5Burl%5D=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fsiemens-healthineers&secure%5Burl_type%5D=linkedin_company_website)  
48,216 employees on LinkedIn®

### [Nanox.AI](https://www.g2.com/products/nanox-ai/reviews)

Nanox.AI is a suite of FDA-cleared artificial intelligence solutions designed to analyze routine medical CT scans and identify early signs of chronic diseases. By leveraging advanced AI algorithms, Nanox.AI assists clinicians in detecting asymptomatic, undiagnosed conditions, facilitating earlier diagnosis and preventive care. This proactive approach aims to improve patient outcomes and reduce the burden on healthcare systems. Key Features and Functionality: - HealthCCSng Cardiac Solution: Automatically detects coronary artery calcification (CAC from routine chest CT scans, aiding in the identification of patients at risk for coronary artery disease without the need for dedicated imaging. - HealthOST Bone Solution: Identifies vertebral compression fractures and low bone mineral density in chest and abdominal CT scans, assisting in the early detection of osteoporosis. - HealthFLD Fatty Liver Solution: Utilizes AI algorithms to detect signs of fatty liver disease in routine CT scans, enabling early intervention strategies. Primary Value and Problem Solved: Nanox.AI addresses the challenge of undiagnosed chronic conditions by extracting actionable insights from existing medical imaging data. Its AI-driven analysis enables healthcare providers to identify at-risk patients earlier in their disease progression, allowing for timely interventions and personalized preventive care plans. This not only enhances patient health outcomes but also optimizes healthcare resources by reducing the incidence of advanced disease complications.

#### Who Is the Company Behind Nanox.AI?

- **Seller:** [Nanox](https://www.g2.com/sellers/nanox)
- **HQ Location:** Petach Tikva, IL
- **LinkedIn® Page:** [www.linkedin.com](https://www.g2.com/external_clickthroughs/record?secure%5Bsource_type%5D=product_profile&secure%5Btoken%5D=48b028586327c043c76f7c029d35b9140e28ea8ddf1e0542b43ded8d186c99d0&secure%5Burl%5D=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fnanox-imaging&secure%5Burl_type%5D=linkedin_company_website)  
110 employees on LinkedIn®

### [qER](https://www.g2.com/products/qer/reviews)

From medical images to connected devices, the amount of medical data being generated is growing exponentially. This coupled with new forms of data such as the ones generated by genome sequencing and biosensors renders traditional diagnostic methods obsolete. At Qure, we are a team of passionate computer scientists, medical practitioners and bioinformaticians who are on a mission to make healthcare more accessible and affordable using the power of deep learning.

#### Who Is the Company Behind qER?

- **Seller:** [Qure.ai](https://www.g2.com/sellers/qure-ai)
- **Year Founded:** 2016
- **HQ Location:** New York , United States
- **LinkedIn® Page:** [www.linkedin.com](https://www.g2.com/external_clickthroughs/record?secure%5Bsource_type%5D=product_profile&secure%5Btoken%5D=907121f84b527eab0597c7e59bae5c35bbde20dd20fe3786b8a15894aa43e0dd&secure%5Burl%5D=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fqure.ai%2F&secure%5Burl_type%5D=linkedin_company_website)  
312 employees on LinkedIn®

### [Qure AI](https://www.g2.com/products/qure-ai-2022-07-05/reviews)

Qure.ai is a pioneering health technology company that leverages artificial intelligence (AI to enhance the accuracy and efficiency of medical imaging diagnostics. By integrating deep learning algorithms with existing radiology equipment, Qure.ai provides automated interpretation of X-rays, CT scans, and ultrasounds, delivering results within seconds. This rapid analysis empowers healthcare professionals to make timely, informed decisions, ultimately improving patient outcomes and making quality healthcare more accessible and affordable worldwide. Key Features and Functionality: - qXR: An AI-driven tool that analyzes chest X-rays to detect over 30 abnormalities, including signs of tuberculosis and lung cancer, in less than a minute. - qER: Designed for brain CT scans, this solution aids in the rapid detection of traumatic brain injuries and strokes, facilitating quicker decision-making in emergency settings. - qCT: An AI-powered tool for chest CT scans, enabling early detection of lung nodules and other abnormalities, crucial for lung cancer screening programs. - qMSK: An innovative AI solution focused on identifying musculoskeletal abnormalities, including fractures, to assist in orthopedic diagnostics. - qTrack: A comprehensive disease management platform that offers end-to-end solutions for screening programs and case management, enhancing care coordination and monitoring through customized dashboards. Primary Value and User Solutions: Qure.ai addresses critical challenges in medical diagnostics by providing AI-powered tools that significantly reduce the time required for image interpretation, thereby expediting diagnosis and treatment. This is particularly vital in time-sensitive situations like stroke care, where rapid intervention can be life-saving. Additionally, by automating routine diagnostic tasks, Qure.ai alleviates the workload of radiologists, allowing them to focus on complex cases. The technology's compatibility with existing imaging equipment ensures seamless integration without the need for costly hardware upgrades, making advanced diagnostic capabilities accessible even in resource-limited settings. Overall, Qure.ai's solutions enhance diagnostic accuracy, streamline clinical workflows, and improve patient outcomes on a global scale.

**Average Rating:** 5.0/5.0

**Total Reviews:** 1

#### Who Is the Company Behind Qure AI?

- **Seller:** [Qure.ai](https://www.g2.com/sellers/qure-ai)
- **Year Founded:** 2016
- **HQ Location:** New York , United States
- **LinkedIn® Page:** [www.linkedin.com](https://www.g2.com/external_clickthroughs/record?secure%5Bsource_type%5D=product_profile&secure%5Btoken%5D=907121f84b527eab0597c7e59bae5c35bbde20dd20fe3786b8a15894aa43e0dd&secure%5Burl%5D=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fqure.ai%2F&secure%5Burl_type%5D=linkedin_company_website)  
312 employees on LinkedIn®

#### Who Uses This Product?

- **Company Size:** 100% Large

#### What Are Recent G2 Reviews of Qure AI?

**["One of the best ever AI product and solution provider for healthcare and research industry"](https://www.g2.com/survey_responses/qure-ai-review-7367257)**

**Rating:** 5.0/5.0 stars

_— Biswajeet S._

[Read full review](https://www.g2.com/survey_responses/qure-ai-review-7367257)

### [Stroke & TBI](https://www.g2.com/products/stroke-tbi/reviews)

qER by Qure.ai is an AI-powered solution designed to enhance the diagnosis and management of stroke and traumatic brain injury (TBI) through rapid and accurate analysis of non-contrast head CT scans. By integrating seamlessly into existing radiology workflows, qER prioritizes critical cases, enabling faster team activation and improved patient outcomes. The system detects and quantifies key abnormalities such as intracranial hemorrhages, cranial fractures, mass effect, and midline shifts, providing clinicians with comprehensive insights to make informed decisions promptly. With regulatory clearances including FDA 510(k) and CE Class IIb certifications, qER is a trusted tool in neuro-critical care settings.

#### Who Is the Company Behind Stroke & TBI?

- **Seller:** [Qure.ai](https://www.g2.com/sellers/qure-ai)
- **Year Founded:** 2016
- **HQ Location:** New York , United States
- **LinkedIn® Page:** [www.linkedin.com](https://www.g2.com/external_clickthroughs/record?secure%5Bsource_type%5D=product_profile&secure%5Btoken%5D=907121f84b527eab0597c7e59bae5c35bbde20dd20fe3786b8a15894aa43e0dd&secure%5Burl%5D=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fqure.ai%2F&secure%5Burl_type%5D=linkedin_company_website)  
312 employees on LinkedIn®

### [TB Care Cascades](https://www.g2.com/products/tb-care-cascades/reviews)

qTrack is an AI-powered platform designed to enhance tuberculosis (TB) care cascades by streamlining screening programs and case management. Leveraging advanced artificial intelligence, qTrack facilitates rapid and accurate analysis of chest X-rays, significantly reducing the time from initial screening to confirmed diagnosis. This efficiency not only accelerates patient care but also optimizes resource utilization within healthcare systems.

#### Who Is the Company Behind TB Care Cascades?

- **Seller:** [Qure.ai](https://www.g2.com/sellers/qure-ai)
- **Year Founded:** 2016
- **HQ Location:** New York , United States
- **LinkedIn® Page:** [www.linkedin.com](https://www.g2.com/external_clickthroughs/record?secure%5Bsource_type%5D=product_profile&secure%5Btoken%5D=907121f84b527eab0597c7e59bae5c35bbde20dd20fe3786b8a15894aa43e0dd&secure%5Burl%5D=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fqure.ai%2F&secure%5Burl_type%5D=linkedin_company_website)  
312 employees on LinkedIn®

### [VUNO Med-BoneAge](https://www.g2.com/products/vuno-med-boneage/reviews)

VUNO Med®-BoneAge™ is an AI-powered diagnostic tool designed to assist healthcare professionals in assessing bone age through the analysis of hand X-ray images. By leveraging deep learning algorithms, it automatically evaluates the X-ray and presents the three most probable bone age candidates, streamlining the diagnostic process and enhancing accuracy. This solution is particularly beneficial in diagnosing growth disorders, such as short stature, tall stature, early or late puberty, and congenital adrenal hyperplasia, by providing precise bone age assessments. Key Features and Functionality: - Automated Bone Age Assessment: Utilizes AI to analyze hand X-ray images, delivering the top three most likely bone age results based on the Greulich-Pyle (GP) method, which categorizes males into 31 groups and females into 27 groups. - Efficient Workflow Integration: Reduces the time required for bone age evaluation by eliminating the need for manual comparison with reference materials. Clinicians can quickly select the most appropriate age from the provided options, enhancing workflow efficiency. - Comprehensive Reporting: Generates detailed reports that include visual graphs projecting the patient's final height, considering factors such as current age, height, and gender. This facilitates clear communication between healthcare providers and patients, improving patient engagement and satisfaction. - Regulatory Approvals: Recognized as Korea's first AI medical device, VUNO Med-BoneAge has received approvals from the Korean Ministry of Food and Drug Safety (MFDS) and the European CE certification, ensuring compliance with international medical standards. Primary Value and User Benefits: VUNO Med-BoneAge addresses the challenges associated with traditional bone age assessment methods, which can be time-consuming and subject to variability among clinicians. By automating the evaluation process, it significantly reduces reading time and enhances the consistency and accuracy of assessments. This leads to more reliable diagnoses of growth-related conditions, enabling timely and appropriate interventions. Additionally, the user-friendly interface and comprehensive reporting support effective communication with patients, fostering better understanding and adherence to treatment plans.

#### Who Is the Company Behind VUNO Med-BoneAge?

- **Seller:** [Vuno](https://www.g2.com/sellers/vuno)
- **Year Founded:** 2014
- **HQ Location:** Seoul, KR
- **LinkedIn® Page:** [www.linkedin.com](https://www.g2.com/external_clickthroughs/record?secure%5Bsource_type%5D=product_profile&secure%5Btoken%5D=9ad8a933574a05ef1b6e3c176e09281d3d072d798b53cf81a1bcfed251f4fe98&secure%5Burl%5D=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fvuno-inc%2F&secure%5Burl_type%5D=linkedin_company_website)  
100 employees on LinkedIn®

### [VUNO Med-Chest X-ray](https://www.g2.com/products/vuno-med-chest-x-ray/reviews)

VUNO Med®-Chest X-ray™ is an AI-powered diagnostic support solution designed to assist healthcare professionals in interpreting chest X-ray images. By analyzing key thoracic abnormalities, it enhances the detection and diagnosis of major lung diseases such as lung cancer, tuberculosis, and pneumonia. Key Features and Functionality: - Detection of Major Abnormalities: The system identifies five critical thoracic findings: nodule/mass, consolidation, interstitial opacity, pneumothorax, and pleural effusion. - Intuitive User Interface: Provides clear visualizations, including abnormality scores and lesion heatmaps, to aid in clinical decision-making. - Seamless Integration: Compatible with Picture Archiving and Communication Systems (PACS) and offers cloud-based services for flexible deployment. - Rapid Analysis: Delivers results in under 10 seconds, facilitating prompt clinical responses. - Regulatory Approvals: Certified by the Korea Ministry of Food and Drug Safety (MFDS) and holds CE certification, ensuring compliance with international medical device standards. Primary Value and User Benefits: VUNO Med®-Chest X-ray™ streamlines the diagnostic process by providing immediate, accurate analysis of chest X-rays, thereby reducing reading times and improving diagnostic accuracy. This efficiency supports healthcare providers in delivering timely and precise patient care, particularly in detecting and managing critical lung conditions.

#### Who Is the Company Behind VUNO Med-Chest X-ray?

- **Seller:** [Vuno](https://www.g2.com/sellers/vuno)
- **Year Founded:** 2014
- **HQ Location:** Seoul, KR
- **LinkedIn® Page:** [www.linkedin.com](https://www.g2.com/external_clickthroughs/record?secure%5Bsource_type%5D=product_profile&secure%5Btoken%5D=9ad8a933574a05ef1b6e3c176e09281d3d072d798b53cf81a1bcfed251f4fe98&secure%5Burl%5D=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fvuno-inc%2F&secure%5Burl_type%5D=linkedin_company_website)  
100 employees on LinkedIn®

### [VUNO Med-DeepBrain](https://www.g2.com/products/vuno-med-deepbrain/reviews)

VUNO Med-DeepBrain is an AI-powered medical device designed to assist in the diagnosis of neurodegenerative diseases by analyzing brain MRI scans. It automates the segmentation and quantification of over 100 brain regions, providing detailed volumetric data, cortical thickness measurements, and white matter hyperintensity assessments. By comparing a patient's brain atrophy data to a normative population, the software generates a comprehensive report with statistical analyses, visual graphs, and diagrams, aiding clinicians in identifying conditions such as Alzheimer's disease and vascular dementia. Key Features and Functionality: - Automated Brain Segmentation: Utilizes deep learning algorithms to divide brain MRI images into more than 100 distinct regions, facilitating precise analysis. - Quantitative Analysis: Provides volumetric measurements, cortical thickness data, and white matter hyperintensity evaluations for each segmented region. - Normative Comparison: Compares individual patient data against age- and gender-matched normative datasets, offering percentile scores to highlight deviations from typical brain structures. - Comprehensive Reporting: Generates customizable reports featuring statistical results, visual graphs, and color-coded overlays to enhance diagnostic interpretation. - Regulatory Approvals: Certified by the U.S. FDA, CE, and MFDS (K-FDA), ensuring compliance with international medical device standards. Primary Value and User Benefits: VUNO Med-DeepBrain streamlines the traditionally manual and time-consuming process of brain MRI analysis, enabling rapid and accurate assessment of neurodegenerative conditions. By providing objective, quantifiable data, it enhances diagnostic precision, supports early detection of diseases like Alzheimer's, and facilitates monitoring of disease progression. This efficiency not only improves patient outcomes through timely intervention but also optimizes clinical workflows, allowing healthcare professionals to allocate more time to patient care.

#### Who Is the Company Behind VUNO Med-DeepBrain?

- **Seller:** [Vuno](https://www.g2.com/sellers/vuno)
- **Year Founded:** 2014
- **HQ Location:** Seoul, KR
- **LinkedIn® Page:** [www.linkedin.com](https://www.g2.com/external_clickthroughs/record?secure%5Bsource_type%5D=product_profile&secure%5Btoken%5D=9ad8a933574a05ef1b6e3c176e09281d3d072d798b53cf81a1bcfed251f4fe98&secure%5Burl%5D=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fvuno-inc%2F&secure%5Burl_type%5D=linkedin_company_website)  
100 employees on LinkedIn®

### [VUNO Med-DeepCARS](https://www.g2.com/products/vuno-med-deepcars/reviews)

VUNO Med®-DeepCARS® is an AI-powered medical device designed to predict the risk of in-hospital cardiac arrest within the next 24 hours for patients in general wards. By continuously analyzing vital signs—including blood pressure, heart rate, respiratory rate, and body temperature—DeepCARS® provides a risk score ranging from 0 to 100, enabling healthcare professionals to monitor patients effectively and manage risks proactively. Key Features and Functionality: - Simplicity: Utilizes only four vital signs to generate a cardiac arrest risk score, facilitating straightforward integration into existing clinical workflows. - Effectiveness: Demonstrated high predictive accuracy in multicenter studies, with an area under the receiver operating characteristic curve (AUROC) of 0.860 in internal validation and 0.905 in external validation. - Efficiency: On average, provides a 15.8-hour lead time from the first prediction to the actual occurrence of cardiac arrest, allowing for timely clinical interventions. Primary Value and User Benefits: DeepCARS® addresses the critical need for early detection of potential cardiac arrests in hospitalized patients. By offering timely and accurate risk assessments, it empowers healthcare providers to intervene proactively, thereby enhancing patient safety and improving clinical outcomes. Its simplicity and efficiency make it a valuable tool in general wards, supporting medical staff in delivering prompt and effective care.

#### Who Is the Company Behind VUNO Med-DeepCARS?

- **Seller:** [Vuno](https://www.g2.com/sellers/vuno)
- **Year Founded:** 2014
- **HQ Location:** Seoul, KR
- **LinkedIn® Page:** [www.linkedin.com](https://www.g2.com/external_clickthroughs/record?secure%5Bsource_type%5D=product_profile&secure%5Btoken%5D=9ad8a933574a05ef1b6e3c176e09281d3d072d798b53cf81a1bcfed251f4fe98&secure%5Burl%5D=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fvuno-inc%2F&secure%5Burl_type%5D=linkedin_company_website)  
100 employees on LinkedIn®

### [VUNO Med-Fundus AI](https://www.g2.com/products/vuno-med-fundus-ai/reviews)

VUNO Med-Fundus AI is an advanced AI-powered diagnostic support solution designed to analyze retinal fundus images, aiding in the detection and diagnosis of various retinal diseases. By leveraging deep learning algorithms trained on a vast dataset of over 100,000 fundus images, this tool provides rapid and accurate identification of critical abnormalities, enhancing the efficiency and accuracy of ophthalmic assessments. Key Features and Functionality: - Detection of 12 Abnormalities: The system identifies and locates twelve essential retinal abnormalities, including drusen, hemorrhage, hard exudate, cotton wool patch, vascular abnormality, glaucomatous disc change, retinal nerve fiber layer defect, membrane, chorioretinal atrophy, non-glaucomatous disc change, macular hole, and myelinated nerve fiber. - Automated Region Mapping: It automatically detects the optic disc and macula, segmenting the fundus into eight regions—macular, superior optic disc, inferior optic disc, temporal, superotemporal, inferotemporal, superonasal, and inferonasal—to assist in precise localization of detected abnormalities. - Comprehensive Patient Reports: The software generates detailed reports that visualize detected anomalies, facilitating clear communication between healthcare providers and patients. Primary Value and User Benefits: VUNO Med-Fundus AI significantly enhances the diagnostic workflow for ophthalmologists by providing swift and accurate detection of retinal abnormalities. This leads to earlier identification of conditions such as diabetic retinopathy, macular degeneration, and glaucoma, which are critical for preventing vision loss. The system's efficiency reduces the time required for image analysis, allowing clinicians to focus more on patient care. Additionally, the clear visualization of findings improves patient understanding and engagement in their treatment plans.

#### Who Is the Company Behind VUNO Med-Fundus AI?

- **Seller:** [Vuno](https://www.g2.com/sellers/vuno)
- **Year Founded:** 2014
- **HQ Location:** Seoul, KR
- **LinkedIn® Page:** [www.linkedin.com](https://www.g2.com/external_clickthroughs/record?secure%5Bsource_type%5D=product_profile&secure%5Btoken%5D=9ad8a933574a05ef1b6e3c176e09281d3d072d798b53cf81a1bcfed251f4fe98&secure%5Burl%5D=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fvuno-inc%2F&secure%5Burl_type%5D=linkedin_company_website)  
100 employees on LinkedIn®

### [VUNO Med-LungCT AI](https://www.g2.com/products/vuno-med-lungct-ai/reviews)

VUNO Med®-LungCT AI™ is an advanced artificial intelligence solution designed to assist healthcare professionals in the detection and analysis of pulmonary nodules from chest CT scans. By leveraging cutting-edge AI algorithms, it enhances the accuracy and efficiency of lung disease diagnoses, providing critical data on nodule size, volume, and location. Key Features and Functionality: - Nodule Detection and Quantification: Identifies pulmonary nodules within chest CT images, offering precise measurements of their size and volume. - Comprehensive Nodule Information: Provides detailed data on nodule type, location, calcification, and spiculation, facilitating thorough assessments. - Lung-RADS Categorization: Automatically classifies nodules according to the Lung-RADS system, aiding in standardized reporting and management. - Longitudinal Tracking: Enables comparison of serial CT scans by matching baseline and follow-up images, assisting in monitoring nodule growth over time. - Integration with PACS: Seamlessly integrates results into Picture Archiving and Communication Systems (PACS) using GSPS objects, ensuring user convenience and streamlined workflow. Primary Value and User Benefits: VUNO Med®-LungCT AI™ addresses the critical need for early detection of lung diseases, particularly lung cancer, by providing rapid and accurate analysis of chest CT scans. Its high sensitivity and low false-positive rate reduce the likelihood of missed diagnoses, thereby improving patient outcomes. The solution's ability to deliver detailed nodule information and standardized categorization enhances diagnostic confidence and supports effective patient management. By integrating seamlessly into existing medical imaging workflows, it minimizes additional workload for radiologists, allowing for more efficient and accurate assessments.

#### Who Is the Company Behind VUNO Med-LungCT AI?

- **Seller:** [Vuno](https://www.g2.com/sellers/vuno)
- **Year Founded:** 2014
- **HQ Location:** Seoul, KR
- **LinkedIn® Page:** [www.linkedin.com](https://www.g2.com/external_clickthroughs/record?secure%5Bsource_type%5D=product_profile&secure%5Btoken%5D=9ad8a933574a05ef1b6e3c176e09281d3d072d798b53cf81a1bcfed251f4fe98&secure%5Burl%5D=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fvuno-inc%2F&secure%5Burl_type%5D=linkedin_company_website)  
100 employees on LinkedIn®

- [‹ Prev‹ Prev](/categories/ai-medical-diagnostic-platforms?order=popular#product-list)
- [1](/categories/ai-medical-diagnostic-platforms?order=popular#product-list)
- 2
- Next ›Next ›

Spotlight Categories

[Event Registration and Ticketing Software](https://www.g2.com/categories/event-registration-ticketing)

[ETL Tools](https://www.g2.com/categories/etl-tools)

[Knowledge Base Software](https://www.g2.com/categories/knowledge-base-software)

[Experience Management Software](https://www.g2.com/categories/experience-management)

[Accounts Receivable Software](https://www.g2.com/categories/accounts-receivable)

Similar Categories

- [AI Patient Engagement & Operations](/categories/ai-patient-engagement-operations)
- [Ambient AI Scribe Platforms](/categories/ambient-ai-scribe-platforms)
- [Ambulatory](/categories/ambulatory)
- [Clinical Documentation](/categories/clinical-documentation)
- [Disease Management](/categories/disease-management)

- [EHR](/categories/ehr)
- [eMAR](/categories/emar)
- [E-Prescribing](/categories/e-prescribing)
- [Healthcare Learning Management Systems (LMS)](/categories/healthcare-learning-management-systems-lms)
- [Health Care Operations](/categories/health-care-operations)

- [HIPAA Compliant Messaging](/categories/hipaa-compliant-messaging)
- [Medical Imaging](/categories/medical-imaging)
- [Medical IoT](/categories/medical-iot)
- [Medical Lab](/categories/medical-lab)
- [Medical Practice Management](/categories/medical-practice-management)

 ![Emma Stein](/assets/transparent-ad5be28fbcd25b7b08d2cebe1d957125437fb5407d75ee717965ad22c8808791.gif "Emma Stein")
ES

Researched and written by [Emma Stein](https://research.g2.com/insights/author/emma-stein)

Updated December 21, 2025

AI medical diagnostic platforms use artificial intelligence to help medical professionals detect diseases, interpret images, and make better diagnostic decisions. These tools review data, such as X-rays, CT scans, lab results, and patient records to identify patterns and flag potential health concerns.

Health care providers use AI-powered diagnostic platforms in hospitals, clinics, imaging labs, and telehealth to help reduce errors, speed up clinical workflows, and prioritize urgent cases. These products support specialists such as radiologists, cardiologists, neurologists, and pathologists by enabling them to review more cases more accurately and efficiently. These tools analyze information within healthcare systems, such as picture archiving and communication systems (PACS), [electronic health records (EHR)](https://www.g2.com/categories/ehr), [radiology information systems (RIS)](https://www.g2.com/categories/radiology-information-systems), or clinical workflow tools.

To qualify for inclusion in the AI Medical Diagnostic Platforms category, a product must:

- Use AI or machine learning (ML) to generate diagnostic output or decision support
- Analyze medical data, including imaging, lab results, or clinical records
- Provide output relevant to detecting, classifying, or flagging diseases or health conditions
- Integrate with health care systems such as picture archiving and communication systems (PACS), electronic health records (EHR), radiology information systems (RIS), or clinical workflow tools
- Complies with relevant regulatory standards

Show More